Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial

被引：0
|
作者：
Amirreza Roostaei Firozabad
Zohreh Akhoundi Meybodi
Seyed Ruhollah Mousavinasab
Adeleh Sahebnasagh
Mohsen Gholinataj Jelodar
Iman Karimzadeh
Solomon Habtemariam
Fatemeh Saghafi
机构：
[1] School of Pharmacy,Pharmaceutical Sciences Research Center, Student Research Committee
[2] Shahid Sadoughi University of Medical Sciences and Health Services,Infectious disease research center
[3] Shahid Sadoughi hospital,Resident of Clinical Pharmacy, Department of Clinical Pharmacy
[4] Shahid Sadoughi University of Medical Sciences,Clinical Research Center, Department of Internal Medicine, School of Medicine
[5] School of Pharmacy,Department of Internal Medicine
[6] Shiraz University of Medical Sciences,Department of Clinical Pharmacy
[7] North Khorasan University of Medical Sciences,Pharmacognosy Research Laboratories and Herbal Analysis Services UK
[8] School of Medicine,Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences Research Center
[9] Shahid Sadoughi University of Medical Sciences,undefined
[10] School of Pharmacy,undefined
[11] Shiraz University of Medical Sciences,undefined
[12] University of Greenwich,undefined
[13] Shahid Sadoughi University of Medical Sciences,undefined
来源：
BMC Infectious Diseases | / 21卷
关键词：
Levamisole; Hydroxychloroquine; COVID-19; SARS-CoV2; Clinical status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial
    Firozabad, Amirreza Roostaei
    Meybodi, Zohreh Akhoundi
    Mousavinasab, Seyed Ruhollah
    Sahebnasagh, Adeleh
    Jelodar, Mohsen Gholinataj
    Karimzadeh, Iman
    Habtemariam, Solomon
    Saghafi, Fatemeh
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [2] Efficacy of levamisole with standard care treatment vs. standard care in clinical presentations of non-hospitalized patients with COVID-19: a randomized clinical trial
    Asgardoon, Mohammad Hossein
    Koochak, Hamid Emadi
    Kazemi-Galougahi, Mohammad Hassan
    Dehnavi, Ali Zare
    Khodaei, Behzad
    Behkar, Atefeh
    Dehpour, Ahmad Reza
    Khalili, Hossein
    Aminianfar, Mohammad
    FRONTIERS IN EMERGENCY MEDICINE, 2022, 6 (03):
  • [3] Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial
    Shah, Muhammad Raza
    Fatima, Samreen
    Khan, Sehrosh Naz
    Ullah, Shafi
    Himani, Gulshan
    Wan, Kelvin
    Lin, Timothy
    Lau, Johnson Y. N.
    Liu, Qingquan
    Lam, Dennis S. C.
    FRONTIERS IN MEDICINE, 2022, 9
  • [4] Efficacy of Nanocurcumin as an Add-On Treatment for Patients Hospitalized with COVID-19: A Double-Blind, Randomized Clinical Trial
    Ahmadi, Sedigheh
    Mehrabi, Zeinab
    Zare, Morteza
    Ghadir, Sara
    Masoumi, Seyed Jalil
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2023, 2023
  • [5] Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19: a randomized clinical trial
    Kaizer, Alexander M.
    Shapiro, Nathan I.
    Wild, Jessica
    Brown, Samuel M.
    Cwik, B. Jessica
    Hart, Kimberly W.
    Jones, Alan E.
    Pulia, Michael S.
    Self, Wesley H.
    Smith, Clay
    Smith, Stephanie A.
    Ng, Patrick C.
    Thompson, B. Taylor
    Rice, Todd W.
    Lindsell, Christopher J.
    Ginde, Adit A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 128 : 223 - 229
  • [6] Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trialAuthor detials
    Jianyi Wei
    Shupeng Liu
    Yuexiang Bian
    Lei Li
    Biyun Qian
    Zixuan Shen
    Yan Zhang
    Adila Abuduaini
    Fuchen Dong
    Xin Zhang
    Jinhui Li
    Yongpei Yu
    Weituo Zhang
    Jun Wang
    Wei Zhai
    Qixiang Song
    Yu Zheng
    Weihua Pan
    Lanlan Yu
    Qimin Zhan
    Ning Zhang
    Junhua Zheng
    Shuming Pan
    Chen Yao
    Hai Li
    Scientific Reports, 15 (1)
  • [7] Efficacy and safety of adding fluoxetine to the treatment regimen of hospitalized patients with non-critical COVID-19 pneumonia: A double-blind randomized, placebo-controlled clinical trial
    Sedighi, Faranak
    Zarghami, Mehran
    Arimi, Fatemeh Alizadeh
    Moosazadeh, Mahmood
    Ala, Shahram
    Ghasemian, Roya
    Mehravaran, Hossein
    Elyasi, Forouzan
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2023, 43 (02) : 202 - 212
  • [8] Efficacy of naproxen in the management of patients hospitalized with COVID-19 infection: A randomized, double-blind, placebo-controlled, clinical trial
    Asadi, Masoomeh
    Sayar, Sara
    Radmanesh, Esmat
    Naghshi, Sina
    Mousaviasl, Sajedeh
    Jelvay, Saeed
    Ebrahimzadeh, Mona
    Mohammadi, Asma
    Abbasi, Samaneh
    Mobarak, Sara
    Bitaraf, Saeid
    Zardehmehri, Fatemeh
    Cheldavi, Ali
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (06)
  • [9] Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
    Maria J. G. T. Vehreschild
    Petar Atanasov
    Kateryna Yurko
    Cristian Oancea
    Georgi Popov
    Valentina Smesnoi
    Gheorghe Placinta
    Hella Kohlhof
    Daniel Vitt
    Evelyn Peelen
    Jelena Mihajlović
    Andreas R. Muehler
    Infectious Diseases and Therapy, 2022, 11 : 2159 - 2176
  • [10] Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
    Vehreschild, Maria J. G. T.
    Atanasov, Petar
    Yurko, Kateryna
    Oancea, Cristian
    Popov, Georgi
    Smesnoi, Valentina
    Placinta, Gheorghe
    Kohlhof, Hella
    Vitt, Daniel
    Peelen, Evelyn
    Mihajlovic, Jelena
    Muehler, Andreas R.
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (06) : 2159 - 2176
12345